CAR-T Therapies on Solid Tumors
Here is an excellent summary by BIOtechNow Editors on the application of CAR-T (Chimeric Antigen Receptor) T-Cell therapies on solid tumors. Up until now CAR-T shows great promise against blood cancers but challenges remain for solid tumors.
Here are some of the major companies engaged in CAR-T:
Bellicum Pharmaceuticals (BLCM), Bluebird bio (BLUE), Cellectis SA (CLLS), Juno Therapeutics (JUNO), Kite Pharma (KITE). Poseida Therapeutics is a private Company.
Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?
Comments
Log in or sign up to join the conversation.